BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1423 related articles for article (PubMed ID: 28355305)

  • 21. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE.
    Lu LH; Wei W; Li SH; Zhang YF; Guo RP
    Aging (Albany NY); 2021 Feb; 13(4):5358-5368. PubMed ID: 33589570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
    Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
    Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
    Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization.
    Liu C; Jia BS; Zou BW; Du H; Yan LN; Yang JY; Jiang L; Wen TF; Lu WS
    Medicine (Baltimore); 2017 Nov; 96(45):e8512. PubMed ID: 29137051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
    Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
    Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.
    Nicolini D; Agostini A; Montalti R; Mocchegiani F; Mincarelli C; Mandolesi A; Robertson NL; Candelari R; Giovagnoni A; Vivarelli M
    World J Gastroenterol; 2017 May; 23(20):3690-3701. PubMed ID: 28611522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of neutrophil to lymphocyte ratio in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Xu X; Chen W; Zhang L; Miao R; Zhou Y; Wan Y; Dong Y; Liu C
    Chin Med J (Engl); 2014; 127(24):4204-9. PubMed ID: 25533822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.
    Op den Winkel M; Nagel D; Op den Winkel P; Trojan J; Paprottka PM; Steib CJ; Schmidt L; Göller M; Stieber P; Göhring P; Herbst A; Rentsch M; De Toni EN; Göke B; Gerbes AL; Kolligs FT
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):44-53. PubMed ID: 29076939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.
    Li X; Chen ZH; Xing YF; Wang TT; Wu DH; Wen JY; Chen J; Lin Q; Dong M; Wei L; Ruan DY; Lin ZX; Wu XY; Ma XK
    Tumour Biol; 2015 Apr; 36(4):2263-9. PubMed ID: 25409616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study.
    Pinato DJ; Arizumi T; Jang JW; Allara E; Suppiah PI; Smirne C; Tait P; Pai M; Grossi G; Kim YW; Pirisi M; Kudo M; Sharma R
    Oncotarget; 2016 Jul; 7(28):44705-44718. PubMed ID: 27244889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
    Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
    Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
    Chen J; Chen YJ; Jiang N; Xu JL; Liang ZM; Bai MJ; Xing YF; Liu Z; Wu XY; Li X
    Oncologist; 2021 Aug; 26(8):e1434-e1444. PubMed ID: 33675070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy.
    Sun S; He C; Wang J; Huang X; Wu J; Li S
    BMC Cancer; 2020 Oct; 20(1):981. PubMed ID: 33036573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Hematological Inflammatory Parameters Predict Mortality in Hepatocellular Carcinoma?
    Dertli R; Asil M; Biyik M; Karakarcayildiz A; Keskin M; Göktepe HM; Kayar Y; Ataseven H
    J Gastrointest Cancer; 2021 Jun; 52(2):666-675. PubMed ID: 32617832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma.
    He Q; Liu Y; Zou Q; Guan YS
    World J Gastroenterol; 2011 May; 17(18):2353-5. PubMed ID: 21633603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma.
    Gao F; Li X; Geng M; Ye X; Liu H; Liu Y; Wan G; Wang X
    Medicine (Baltimore); 2015 Mar; 94(11):e639. PubMed ID: 25789957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
    Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
    Front Immunol; 2021; 12():691364. PubMed ID: 34248983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.